Yousif Capital Management’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,943
Closed -$294K 1709
2026
Q1
$294K Hold
10,943
﹤0.01% 1622
2025
Q4
$343K Hold
10,943
﹤0.01% 1582
2025
Q3
$336K Hold
10,943
﹤0.01% 1593
2025
Q2
$226K Buy
10,943
+790
+8% +$16.2K ﹤0.01% 1783
2025
Q1
$199K Hold
10,153
﹤0.01% 1810
2024
Q4
$212K Hold
10,153
﹤0.01% 1807
2024
Q3
$248K Sell
10,153
-378
-4% -$10.1K ﹤0.01% 1795
2024
Q2
$265K Sell
10,531
-655
-6% -$18.6K ﹤0.01% 1738
2024
Q1
$335K Hold
11,186
﹤0.01% 1691
2023
Q4
$356K Hold
11,186
﹤0.01% 1693
2023
Q3
$395K Hold
11,186
0.01% 1597
2023
Q2
$425K Buy
11,186
+194
+2% +$7.74K 0.01% 1556
2023
Q1
$415K Hold
10,992
0.01% 1563
2022
Q4
$466K Hold
10,992
0.01% 1529
2022
Q3
$353K Buy
10,992
+890
+9% +$31.3K 0.01% 1646
2022
Q2
$328K Sell
10,102
-70
-0.7% -$2.27K ﹤0.01% 1698
2022
Q1
$368K Hold
10,172
﹤0.01% 1740
2021
Q4
$402K Buy
+10,172
New +$424K ﹤0.01% 1729

Other funds holding GMAB

Yousif Capital Management's GMAB Position: Q2 2026 in Review

Yousif Capital Management sold out of Genmab (GMAB) in Q2 2026, closing a stake of 10,943 shares — an estimated $294K sold.

Yousif Capital Management first reported a position in GMAB in Q4 2021 and held it in 18 quarters. The position peaked at $466K in Q4 2022. 122 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Yousif Capital Management reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • Yousif Capital Management sold 10,943 Genmab shares in Q2 2026, an estimated $294K.
  • Yousif Capital Management first reported a position in Genmab in Q4 2021 and held it in 18 quarters.
  • Yousif Capital Management's Genmab position peaked at $466K in Q4 2022.
  • 122 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.